Review



ag490 89  (TargetMol)


Bioz Verified Symbol TargetMol is a verified supplier
Bioz Manufacturer Symbol TargetMol manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    TargetMol ag490 89
    Ag490 89, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ag490 89/product/TargetMol
    Average 93 stars, based on 9 article reviews
    ag490 89 - by Bioz Stars, 2026-05
    93/100 stars

    Images



    Similar Products

    96
    MedChemExpress chemical inhibitors ag490
    Chemical Inhibitors Ag490, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/chemical inhibitors ag490/product/MedChemExpress
    Average 96 stars, based on 1 article reviews
    chemical inhibitors ag490 - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    93
    TargetMol ag490 89
    Ag490 89, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ag490 89/product/TargetMol
    Average 93 stars, based on 1 article reviews
    ag490 89 - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    96
    MedChemExpress ag490
    Ag490, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ag490/product/MedChemExpress
    Average 96 stars, based on 1 article reviews
    ag490 - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    94
    MedChemExpress ag490 cat hy 12003 mce
    p-JAK2/JAK2 and p-STAT3/STAT3 were highly expressed in OLP. <t>AG490</t> and RPM inhibited KCs proliferation. AG490 and RPM inhibited homing migration of OLP IELs. (A–C) p-JAK2/JAK2 and p-STAT3/STAT3 were significantly upregulated in OLP compared to controls (n = 6), as detected by western blot. (D) In the MTT assay, at 48 h, the OD450 values of the AG490 group, RPM group, and AG490+RPM group were significantly lower than those of the Control group. Compared with the AG490 group and RPM group, the OD450 values of the AG490+RPM group were significantly reduced. Additionally, the OD450 values of the AG490 group were significantly lower than those of the RPM group. (E) Compared with the control group, the AG490 group and RPM group exhibited a significant reduction in the number of migration tracks, while the AG490+RPM group showed a significantly reduced number of tracks. (F, G) Compared with the control group, the AG490 group and RPM group demonstrated a significant decrease in both speed and maximum displacement, and the AG490+RPM group exhibited a significant reduction in both speed and maximum displacement. * p < 0.05; ** p < 0.01; *** p < 0.001. JAK2, Janus kinase 2; p-JAK2, Phosphorylated Janus kinase 2; STAT3, Signal transducer and activator of transcription 3; p-STAT3, Phosphorylated signal transducer and activator of transcription 3; OD, Optical density; AG490, (E)-N-Benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide; RPM, Ruxolitinib.
    Ag490 Cat Hy 12003 Mce, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ag490 cat hy 12003 mce/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    ag490 cat hy 12003 mce - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    96
    MedChemExpress ag490 group
    p-JAK2/JAK2 and p-STAT3/STAT3 were highly expressed in OLP. <t>AG490</t> and RPM inhibited KCs proliferation. AG490 and RPM inhibited homing migration of OLP IELs. (A–C) p-JAK2/JAK2 and p-STAT3/STAT3 were significantly upregulated in OLP compared to controls (n = 6), as detected by western blot. (D) In the MTT assay, at 48 h, the OD450 values of the AG490 group, RPM group, and AG490+RPM group were significantly lower than those of the Control group. Compared with the AG490 group and RPM group, the OD450 values of the AG490+RPM group were significantly reduced. Additionally, the OD450 values of the AG490 group were significantly lower than those of the RPM group. (E) Compared with the control group, the AG490 group and RPM group exhibited a significant reduction in the number of migration tracks, while the AG490+RPM group showed a significantly reduced number of tracks. (F, G) Compared with the control group, the AG490 group and RPM group demonstrated a significant decrease in both speed and maximum displacement, and the AG490+RPM group exhibited a significant reduction in both speed and maximum displacement. * p < 0.05; ** p < 0.01; *** p < 0.001. JAK2, Janus kinase 2; p-JAK2, Phosphorylated Janus kinase 2; STAT3, Signal transducer and activator of transcription 3; p-STAT3, Phosphorylated signal transducer and activator of transcription 3; OD, Optical density; AG490, (E)-N-Benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide; RPM, Ruxolitinib.
    Ag490 Group, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ag490 group/product/MedChemExpress
    Average 96 stars, based on 1 article reviews
    ag490 group - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    96
    MedChemExpress stat3 inhibitor ag490
    p-JAK2/JAK2 and p-STAT3/STAT3 were highly expressed in OLP. <t>AG490</t> and RPM inhibited KCs proliferation. AG490 and RPM inhibited homing migration of OLP IELs. (A–C) p-JAK2/JAK2 and p-STAT3/STAT3 were significantly upregulated in OLP compared to controls (n = 6), as detected by western blot. (D) In the MTT assay, at 48 h, the OD450 values of the AG490 group, RPM group, and AG490+RPM group were significantly lower than those of the Control group. Compared with the AG490 group and RPM group, the OD450 values of the AG490+RPM group were significantly reduced. Additionally, the OD450 values of the AG490 group were significantly lower than those of the RPM group. (E) Compared with the control group, the AG490 group and RPM group exhibited a significant reduction in the number of migration tracks, while the AG490+RPM group showed a significantly reduced number of tracks. (F, G) Compared with the control group, the AG490 group and RPM group demonstrated a significant decrease in both speed and maximum displacement, and the AG490+RPM group exhibited a significant reduction in both speed and maximum displacement. * p < 0.05; ** p < 0.01; *** p < 0.001. JAK2, Janus kinase 2; p-JAK2, Phosphorylated Janus kinase 2; STAT3, Signal transducer and activator of transcription 3; p-STAT3, Phosphorylated signal transducer and activator of transcription 3; OD, Optical density; AG490, (E)-N-Benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide; RPM, Ruxolitinib.
    Stat3 Inhibitor Ag490, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/stat3 inhibitor ag490/product/MedChemExpress
    Average 96 stars, based on 1 article reviews
    stat3 inhibitor ag490 - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    Image Search Results


    p-JAK2/JAK2 and p-STAT3/STAT3 were highly expressed in OLP. AG490 and RPM inhibited KCs proliferation. AG490 and RPM inhibited homing migration of OLP IELs. (A–C) p-JAK2/JAK2 and p-STAT3/STAT3 were significantly upregulated in OLP compared to controls (n = 6), as detected by western blot. (D) In the MTT assay, at 48 h, the OD450 values of the AG490 group, RPM group, and AG490+RPM group were significantly lower than those of the Control group. Compared with the AG490 group and RPM group, the OD450 values of the AG490+RPM group were significantly reduced. Additionally, the OD450 values of the AG490 group were significantly lower than those of the RPM group. (E) Compared with the control group, the AG490 group and RPM group exhibited a significant reduction in the number of migration tracks, while the AG490+RPM group showed a significantly reduced number of tracks. (F, G) Compared with the control group, the AG490 group and RPM group demonstrated a significant decrease in both speed and maximum displacement, and the AG490+RPM group exhibited a significant reduction in both speed and maximum displacement. * p < 0.05; ** p < 0.01; *** p < 0.001. JAK2, Janus kinase 2; p-JAK2, Phosphorylated Janus kinase 2; STAT3, Signal transducer and activator of transcription 3; p-STAT3, Phosphorylated signal transducer and activator of transcription 3; OD, Optical density; AG490, (E)-N-Benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide; RPM, Ruxolitinib.

    Journal: Frontiers in Immunology

    Article Title: Keratinocytes regulate intraepithelial lymphocytes homing and mediate mucosal barrier integrity via JAK2/STAT3 signaling in oral lichen planus

    doi: 10.3389/fimmu.2026.1794867

    Figure Lengend Snippet: p-JAK2/JAK2 and p-STAT3/STAT3 were highly expressed in OLP. AG490 and RPM inhibited KCs proliferation. AG490 and RPM inhibited homing migration of OLP IELs. (A–C) p-JAK2/JAK2 and p-STAT3/STAT3 were significantly upregulated in OLP compared to controls (n = 6), as detected by western blot. (D) In the MTT assay, at 48 h, the OD450 values of the AG490 group, RPM group, and AG490+RPM group were significantly lower than those of the Control group. Compared with the AG490 group and RPM group, the OD450 values of the AG490+RPM group were significantly reduced. Additionally, the OD450 values of the AG490 group were significantly lower than those of the RPM group. (E) Compared with the control group, the AG490 group and RPM group exhibited a significant reduction in the number of migration tracks, while the AG490+RPM group showed a significantly reduced number of tracks. (F, G) Compared with the control group, the AG490 group and RPM group demonstrated a significant decrease in both speed and maximum displacement, and the AG490+RPM group exhibited a significant reduction in both speed and maximum displacement. * p < 0.05; ** p < 0.01; *** p < 0.001. JAK2, Janus kinase 2; p-JAK2, Phosphorylated Janus kinase 2; STAT3, Signal transducer and activator of transcription 3; p-STAT3, Phosphorylated signal transducer and activator of transcription 3; OD, Optical density; AG490, (E)-N-Benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide; RPM, Ruxolitinib.

    Article Snippet: The models were divided into four groups based on the addition of inhibitors: (1) Control group (treated with K-SFM medium containing an equal concentration of PBS); (2) AG490 group (treated with K-SFM medium containing 50 μmol/L AG490) (AG490, Cat # HY-12003, MCE); (3) RPM group (treated with K-SFM medium containing 20 nmol/L RPM) (RPM, Cat # HY-10219, MCE); and (4) AG490+RPM group (treated with K-SFM medium containing 50 μmol/L AG490 and 20 nmol/L RPM).

    Techniques: Migration, Western Blot, MTT Assay, Control

    AG490 and RPM inhibited the expression of apoptosis-related proteins Bax and caspase-3 and promoted the expression of Bcl-2, as measured by ELISA. (a), compared with control, p < 0.05; (b), compared with AG490 group, p < 0.05; (c), compared with RPM group, p < 0.05. AG490, (E)-N-Benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide; RPM, Ruxolitinib; Bax, Bcl-2 associated X protein; Bcl-2, B-cell lymphoma/leukemia-2 gene; caspase-3, Cysteine-dependent aspartate-specific protease-3.

    Journal: Frontiers in Immunology

    Article Title: Keratinocytes regulate intraepithelial lymphocytes homing and mediate mucosal barrier integrity via JAK2/STAT3 signaling in oral lichen planus

    doi: 10.3389/fimmu.2026.1794867

    Figure Lengend Snippet: AG490 and RPM inhibited the expression of apoptosis-related proteins Bax and caspase-3 and promoted the expression of Bcl-2, as measured by ELISA. (a), compared with control, p < 0.05; (b), compared with AG490 group, p < 0.05; (c), compared with RPM group, p < 0.05. AG490, (E)-N-Benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide; RPM, Ruxolitinib; Bax, Bcl-2 associated X protein; Bcl-2, B-cell lymphoma/leukemia-2 gene; caspase-3, Cysteine-dependent aspartate-specific protease-3.

    Article Snippet: The models were divided into four groups based on the addition of inhibitors: (1) Control group (treated with K-SFM medium containing an equal concentration of PBS); (2) AG490 group (treated with K-SFM medium containing 50 μmol/L AG490) (AG490, Cat # HY-12003, MCE); (3) RPM group (treated with K-SFM medium containing 20 nmol/L RPM) (RPM, Cat # HY-10219, MCE); and (4) AG490+RPM group (treated with K-SFM medium containing 50 μmol/L AG490 and 20 nmol/L RPM).

    Techniques: Expressing, Enzyme-linked Immunosorbent Assay, Control

    AG490 and RPM synergistically inhibited the phosphorylation of JAK2/STAT3. (A, B) AG490 and RPM selectively inhibited JAK2/STAT3 phosphorylation. * p < 0.05; ** p < 0.01; *** p < 0.001. (C) JAK2 and p-JAK2 were downregulated in AG490 and AG490+RPM group. (D) STAT3 and p-STAT3 were downregulated in RPM and AG490+RPM group. (E) Compared with the control group, the protein ratios of p-JAK2/JAK2 and p-STAT3/STAT3 were significantly increased in the AG490 group, RPM group, and AG490+RPM group. Compared with the AG490 group and RPM group, the protein ratios of p-JAK2/JAK2 and p-STAT3/STAT3 were significantly decreased in the AG490+RPM group. a, compared with control, p < 0.05; b, compared with AG490 group, p < 0.05; c, compared with RPM group, p < 0.05; aa, compared with control, p < 0.01. AG490, (E)-N-Benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide; RPM, Ruxolitinib; JAK2, Janus kinase 2; p-JAK2, Phosphorylated Janus kinase 2; STAT3, Signal transducer and activator of transcription 3; p-STAT3: Phosphorylated signal transducer and activator of transcription 3; GAPDH, Glycerol-3-phosphate dehydrogenase.

    Journal: Frontiers in Immunology

    Article Title: Keratinocytes regulate intraepithelial lymphocytes homing and mediate mucosal barrier integrity via JAK2/STAT3 signaling in oral lichen planus

    doi: 10.3389/fimmu.2026.1794867

    Figure Lengend Snippet: AG490 and RPM synergistically inhibited the phosphorylation of JAK2/STAT3. (A, B) AG490 and RPM selectively inhibited JAK2/STAT3 phosphorylation. * p < 0.05; ** p < 0.01; *** p < 0.001. (C) JAK2 and p-JAK2 were downregulated in AG490 and AG490+RPM group. (D) STAT3 and p-STAT3 were downregulated in RPM and AG490+RPM group. (E) Compared with the control group, the protein ratios of p-JAK2/JAK2 and p-STAT3/STAT3 were significantly increased in the AG490 group, RPM group, and AG490+RPM group. Compared with the AG490 group and RPM group, the protein ratios of p-JAK2/JAK2 and p-STAT3/STAT3 were significantly decreased in the AG490+RPM group. a, compared with control, p < 0.05; b, compared with AG490 group, p < 0.05; c, compared with RPM group, p < 0.05; aa, compared with control, p < 0.01. AG490, (E)-N-Benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide; RPM, Ruxolitinib; JAK2, Janus kinase 2; p-JAK2, Phosphorylated Janus kinase 2; STAT3, Signal transducer and activator of transcription 3; p-STAT3: Phosphorylated signal transducer and activator of transcription 3; GAPDH, Glycerol-3-phosphate dehydrogenase.

    Article Snippet: The models were divided into four groups based on the addition of inhibitors: (1) Control group (treated with K-SFM medium containing an equal concentration of PBS); (2) AG490 group (treated with K-SFM medium containing 50 μmol/L AG490) (AG490, Cat # HY-12003, MCE); (3) RPM group (treated with K-SFM medium containing 20 nmol/L RPM) (RPM, Cat # HY-10219, MCE); and (4) AG490+RPM group (treated with K-SFM medium containing 50 μmol/L AG490 and 20 nmol/L RPM).

    Techniques: Phospho-proteomics, Control

    The expression of ZO-1 and Occludin mRNA was upregulated after using AG490 and RPM. (A, B) Compared with the control group, the expression of ZO-1 and Occludin mRNA increased in the AG490 group. The expression of ZO-1 and Occludin mRAN in the RPM group was upregulated. The expression of ZO-1 and Occludin mRNA was significantly increased in the AG490+RPM group. Compared with the RPM group, the AG490+RPM group showed increased expression of ZO-1 and Occludin mRNA. * p < 0.05; ** p < 0.01; *** p < 0.001. (C) Schematic diagram of the regulatory network mechanism involving E-cadherin/CD103-JAK2/STAT3-ZO-1/Occludin in OLP. The binding of E-cadherin/CD103 downregulated JAK2/STAT3 phosphorylation in KCs and upregulated mucosal barrier molecules ZO-1 and Occludin, which helped maintain the integrity of the mucosal barrier. CD103, Integrin alpha-E; E-cadherin, Epithelial cadherin; JAK2, Janus kinase 2; STAT3, Signal transducer and activator of transcription 3; AG490, (E)-N-Benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide; RPM, Ruxolitinib; ZO-1, Zonula occludens protein 1; KC, Keratinocytes; IEL, Intraepithelial lymphocyte.

    Journal: Frontiers in Immunology

    Article Title: Keratinocytes regulate intraepithelial lymphocytes homing and mediate mucosal barrier integrity via JAK2/STAT3 signaling in oral lichen planus

    doi: 10.3389/fimmu.2026.1794867

    Figure Lengend Snippet: The expression of ZO-1 and Occludin mRNA was upregulated after using AG490 and RPM. (A, B) Compared with the control group, the expression of ZO-1 and Occludin mRNA increased in the AG490 group. The expression of ZO-1 and Occludin mRAN in the RPM group was upregulated. The expression of ZO-1 and Occludin mRNA was significantly increased in the AG490+RPM group. Compared with the RPM group, the AG490+RPM group showed increased expression of ZO-1 and Occludin mRNA. * p < 0.05; ** p < 0.01; *** p < 0.001. (C) Schematic diagram of the regulatory network mechanism involving E-cadherin/CD103-JAK2/STAT3-ZO-1/Occludin in OLP. The binding of E-cadherin/CD103 downregulated JAK2/STAT3 phosphorylation in KCs and upregulated mucosal barrier molecules ZO-1 and Occludin, which helped maintain the integrity of the mucosal barrier. CD103, Integrin alpha-E; E-cadherin, Epithelial cadherin; JAK2, Janus kinase 2; STAT3, Signal transducer and activator of transcription 3; AG490, (E)-N-Benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide; RPM, Ruxolitinib; ZO-1, Zonula occludens protein 1; KC, Keratinocytes; IEL, Intraepithelial lymphocyte.

    Article Snippet: The models were divided into four groups based on the addition of inhibitors: (1) Control group (treated with K-SFM medium containing an equal concentration of PBS); (2) AG490 group (treated with K-SFM medium containing 50 μmol/L AG490) (AG490, Cat # HY-12003, MCE); (3) RPM group (treated with K-SFM medium containing 20 nmol/L RPM) (RPM, Cat # HY-10219, MCE); and (4) AG490+RPM group (treated with K-SFM medium containing 50 μmol/L AG490 and 20 nmol/L RPM).

    Techniques: Expressing, Control, Binding Assay, Phospho-proteomics

    p-JAK2/JAK2 and p-STAT3/STAT3 were highly expressed in OLP. AG490 and RPM inhibited KCs proliferation. AG490 and RPM inhibited homing migration of OLP IELs. (A–C) p-JAK2/JAK2 and p-STAT3/STAT3 were significantly upregulated in OLP compared to controls (n = 6), as detected by western blot. (D) In the MTT assay, at 48 h, the OD450 values of the AG490 group, RPM group, and AG490+RPM group were significantly lower than those of the Control group. Compared with the AG490 group and RPM group, the OD450 values of the AG490+RPM group were significantly reduced. Additionally, the OD450 values of the AG490 group were significantly lower than those of the RPM group. (E) Compared with the control group, the AG490 group and RPM group exhibited a significant reduction in the number of migration tracks, while the AG490+RPM group showed a significantly reduced number of tracks. (F, G) Compared with the control group, the AG490 group and RPM group demonstrated a significant decrease in both speed and maximum displacement, and the AG490+RPM group exhibited a significant reduction in both speed and maximum displacement. * p < 0.05; ** p < 0.01; *** p < 0.001. JAK2, Janus kinase 2; p-JAK2, Phosphorylated Janus kinase 2; STAT3, Signal transducer and activator of transcription 3; p-STAT3, Phosphorylated signal transducer and activator of transcription 3; OD, Optical density; AG490, (E)-N-Benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide; RPM, Ruxolitinib.

    Journal: Frontiers in Immunology

    Article Title: Keratinocytes regulate intraepithelial lymphocytes homing and mediate mucosal barrier integrity via JAK2/STAT3 signaling in oral lichen planus

    doi: 10.3389/fimmu.2026.1794867

    Figure Lengend Snippet: p-JAK2/JAK2 and p-STAT3/STAT3 were highly expressed in OLP. AG490 and RPM inhibited KCs proliferation. AG490 and RPM inhibited homing migration of OLP IELs. (A–C) p-JAK2/JAK2 and p-STAT3/STAT3 were significantly upregulated in OLP compared to controls (n = 6), as detected by western blot. (D) In the MTT assay, at 48 h, the OD450 values of the AG490 group, RPM group, and AG490+RPM group were significantly lower than those of the Control group. Compared with the AG490 group and RPM group, the OD450 values of the AG490+RPM group were significantly reduced. Additionally, the OD450 values of the AG490 group were significantly lower than those of the RPM group. (E) Compared with the control group, the AG490 group and RPM group exhibited a significant reduction in the number of migration tracks, while the AG490+RPM group showed a significantly reduced number of tracks. (F, G) Compared with the control group, the AG490 group and RPM group demonstrated a significant decrease in both speed and maximum displacement, and the AG490+RPM group exhibited a significant reduction in both speed and maximum displacement. * p < 0.05; ** p < 0.01; *** p < 0.001. JAK2, Janus kinase 2; p-JAK2, Phosphorylated Janus kinase 2; STAT3, Signal transducer and activator of transcription 3; p-STAT3, Phosphorylated signal transducer and activator of transcription 3; OD, Optical density; AG490, (E)-N-Benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide; RPM, Ruxolitinib.

    Article Snippet: The models were divided into four groups based on the addition of inhibitors: (1) Control group (treated with K-SFM medium containing an equal concentration of PBS); (2) AG490 group (treated with K-SFM medium containing 50 μmol/L AG490) (AG490, Cat # HY-12003, MCE); (3) RPM group (treated with K-SFM medium containing 20 nmol/L RPM) (RPM, Cat # HY-10219, MCE); and (4) AG490+RPM group (treated with K-SFM medium containing 50 μmol/L AG490 and 20 nmol/L RPM).

    Techniques: Migration, Western Blot, MTT Assay, Control

    AG490 and RPM inhibited the expression of apoptosis-related proteins Bax and caspase-3 and promoted the expression of Bcl-2, as measured by ELISA. (a), compared with control, p < 0.05; (b), compared with AG490 group, p < 0.05; (c), compared with RPM group, p < 0.05. AG490, (E)-N-Benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide; RPM, Ruxolitinib; Bax, Bcl-2 associated X protein; Bcl-2, B-cell lymphoma/leukemia-2 gene; caspase-3, Cysteine-dependent aspartate-specific protease-3.

    Journal: Frontiers in Immunology

    Article Title: Keratinocytes regulate intraepithelial lymphocytes homing and mediate mucosal barrier integrity via JAK2/STAT3 signaling in oral lichen planus

    doi: 10.3389/fimmu.2026.1794867

    Figure Lengend Snippet: AG490 and RPM inhibited the expression of apoptosis-related proteins Bax and caspase-3 and promoted the expression of Bcl-2, as measured by ELISA. (a), compared with control, p < 0.05; (b), compared with AG490 group, p < 0.05; (c), compared with RPM group, p < 0.05. AG490, (E)-N-Benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide; RPM, Ruxolitinib; Bax, Bcl-2 associated X protein; Bcl-2, B-cell lymphoma/leukemia-2 gene; caspase-3, Cysteine-dependent aspartate-specific protease-3.

    Article Snippet: The models were divided into four groups based on the addition of inhibitors: (1) Control group (treated with K-SFM medium containing an equal concentration of PBS); (2) AG490 group (treated with K-SFM medium containing 50 μmol/L AG490) (AG490, Cat # HY-12003, MCE); (3) RPM group (treated with K-SFM medium containing 20 nmol/L RPM) (RPM, Cat # HY-10219, MCE); and (4) AG490+RPM group (treated with K-SFM medium containing 50 μmol/L AG490 and 20 nmol/L RPM).

    Techniques: Expressing, Enzyme-linked Immunosorbent Assay, Control

    AG490 and RPM synergistically inhibited the phosphorylation of JAK2/STAT3. (A, B) AG490 and RPM selectively inhibited JAK2/STAT3 phosphorylation. * p < 0.05; ** p < 0.01; *** p < 0.001. (C) JAK2 and p-JAK2 were downregulated in AG490 and AG490+RPM group. (D) STAT3 and p-STAT3 were downregulated in RPM and AG490+RPM group. (E) Compared with the control group, the protein ratios of p-JAK2/JAK2 and p-STAT3/STAT3 were significantly increased in the AG490 group, RPM group, and AG490+RPM group. Compared with the AG490 group and RPM group, the protein ratios of p-JAK2/JAK2 and p-STAT3/STAT3 were significantly decreased in the AG490+RPM group. a, compared with control, p < 0.05; b, compared with AG490 group, p < 0.05; c, compared with RPM group, p < 0.05; aa, compared with control, p < 0.01. AG490, (E)-N-Benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide; RPM, Ruxolitinib; JAK2, Janus kinase 2; p-JAK2, Phosphorylated Janus kinase 2; STAT3, Signal transducer and activator of transcription 3; p-STAT3: Phosphorylated signal transducer and activator of transcription 3; GAPDH, Glycerol-3-phosphate dehydrogenase.

    Journal: Frontiers in Immunology

    Article Title: Keratinocytes regulate intraepithelial lymphocytes homing and mediate mucosal barrier integrity via JAK2/STAT3 signaling in oral lichen planus

    doi: 10.3389/fimmu.2026.1794867

    Figure Lengend Snippet: AG490 and RPM synergistically inhibited the phosphorylation of JAK2/STAT3. (A, B) AG490 and RPM selectively inhibited JAK2/STAT3 phosphorylation. * p < 0.05; ** p < 0.01; *** p < 0.001. (C) JAK2 and p-JAK2 were downregulated in AG490 and AG490+RPM group. (D) STAT3 and p-STAT3 were downregulated in RPM and AG490+RPM group. (E) Compared with the control group, the protein ratios of p-JAK2/JAK2 and p-STAT3/STAT3 were significantly increased in the AG490 group, RPM group, and AG490+RPM group. Compared with the AG490 group and RPM group, the protein ratios of p-JAK2/JAK2 and p-STAT3/STAT3 were significantly decreased in the AG490+RPM group. a, compared with control, p < 0.05; b, compared with AG490 group, p < 0.05; c, compared with RPM group, p < 0.05; aa, compared with control, p < 0.01. AG490, (E)-N-Benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide; RPM, Ruxolitinib; JAK2, Janus kinase 2; p-JAK2, Phosphorylated Janus kinase 2; STAT3, Signal transducer and activator of transcription 3; p-STAT3: Phosphorylated signal transducer and activator of transcription 3; GAPDH, Glycerol-3-phosphate dehydrogenase.

    Article Snippet: The models were divided into four groups based on the addition of inhibitors: (1) Control group (treated with K-SFM medium containing an equal concentration of PBS); (2) AG490 group (treated with K-SFM medium containing 50 μmol/L AG490) (AG490, Cat # HY-12003, MCE); (3) RPM group (treated with K-SFM medium containing 20 nmol/L RPM) (RPM, Cat # HY-10219, MCE); and (4) AG490+RPM group (treated with K-SFM medium containing 50 μmol/L AG490 and 20 nmol/L RPM).

    Techniques: Phospho-proteomics, Control

    The expression of ZO-1 and Occludin mRNA was upregulated after using AG490 and RPM. (A, B) Compared with the control group, the expression of ZO-1 and Occludin mRNA increased in the AG490 group. The expression of ZO-1 and Occludin mRAN in the RPM group was upregulated. The expression of ZO-1 and Occludin mRNA was significantly increased in the AG490+RPM group. Compared with the RPM group, the AG490+RPM group showed increased expression of ZO-1 and Occludin mRNA. * p < 0.05; ** p < 0.01; *** p < 0.001. (C) Schematic diagram of the regulatory network mechanism involving E-cadherin/CD103-JAK2/STAT3-ZO-1/Occludin in OLP. The binding of E-cadherin/CD103 downregulated JAK2/STAT3 phosphorylation in KCs and upregulated mucosal barrier molecules ZO-1 and Occludin, which helped maintain the integrity of the mucosal barrier. CD103, Integrin alpha-E; E-cadherin, Epithelial cadherin; JAK2, Janus kinase 2; STAT3, Signal transducer and activator of transcription 3; AG490, (E)-N-Benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide; RPM, Ruxolitinib; ZO-1, Zonula occludens protein 1; KC, Keratinocytes; IEL, Intraepithelial lymphocyte.

    Journal: Frontiers in Immunology

    Article Title: Keratinocytes regulate intraepithelial lymphocytes homing and mediate mucosal barrier integrity via JAK2/STAT3 signaling in oral lichen planus

    doi: 10.3389/fimmu.2026.1794867

    Figure Lengend Snippet: The expression of ZO-1 and Occludin mRNA was upregulated after using AG490 and RPM. (A, B) Compared with the control group, the expression of ZO-1 and Occludin mRNA increased in the AG490 group. The expression of ZO-1 and Occludin mRAN in the RPM group was upregulated. The expression of ZO-1 and Occludin mRNA was significantly increased in the AG490+RPM group. Compared with the RPM group, the AG490+RPM group showed increased expression of ZO-1 and Occludin mRNA. * p < 0.05; ** p < 0.01; *** p < 0.001. (C) Schematic diagram of the regulatory network mechanism involving E-cadherin/CD103-JAK2/STAT3-ZO-1/Occludin in OLP. The binding of E-cadherin/CD103 downregulated JAK2/STAT3 phosphorylation in KCs and upregulated mucosal barrier molecules ZO-1 and Occludin, which helped maintain the integrity of the mucosal barrier. CD103, Integrin alpha-E; E-cadherin, Epithelial cadherin; JAK2, Janus kinase 2; STAT3, Signal transducer and activator of transcription 3; AG490, (E)-N-Benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide; RPM, Ruxolitinib; ZO-1, Zonula occludens protein 1; KC, Keratinocytes; IEL, Intraepithelial lymphocyte.

    Article Snippet: The models were divided into four groups based on the addition of inhibitors: (1) Control group (treated with K-SFM medium containing an equal concentration of PBS); (2) AG490 group (treated with K-SFM medium containing 50 μmol/L AG490) (AG490, Cat # HY-12003, MCE); (3) RPM group (treated with K-SFM medium containing 20 nmol/L RPM) (RPM, Cat # HY-10219, MCE); and (4) AG490+RPM group (treated with K-SFM medium containing 50 μmol/L AG490 and 20 nmol/L RPM).

    Techniques: Expressing, Control, Binding Assay, Phospho-proteomics